244 related articles for article (PubMed ID: 22767346)
1. HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy.
Nicastri E; Dori L; Buonomini AR; Tommasi C; De Nardo P; Bellagamba R; Corpolongo A; Montano M; Sordillo P; Volpi A; Sarmati L; Andreoni M
AIDS; 2012 Jul; 26(11):1451-2. PubMed ID: 22767346
[No Abstract] [Full Text] [Related]
2. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
[TBL] [Abstract][Full Text] [Related]
3. Discordant movement of CD4-positive T-cell count in HIV-1 infected patients with HAART failure.
Okano A; Matsuda M; Chiba T; Moriya K; Yamada K; Sugiura W
Jpn J Infect Dis; 2002 Apr; 55(2):62-5. PubMed ID: 12082315
[No Abstract] [Full Text] [Related]
4. Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.
Wit FW; Blanckenberg DH; Brinkman K; Prins JM; van der Ende ME; Schneider MM; Mulder JW; de Wolf F; Lange JM;
AIDS; 2005 Feb; 19(3):345-8. PubMed ID: 15718848
[TBL] [Abstract][Full Text] [Related]
5. Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.
Abbas UL; Mellors JW
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13377-8. PubMed ID: 12370421
[No Abstract] [Full Text] [Related]
6. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
[TBL] [Abstract][Full Text] [Related]
7. Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.
Sanchez R; Portilla J; Gimeno A; Boix V; Llopis C; Sanchez-Paya J; Merino E; de la Sen ML; Muñoz C; Reus S; Plazas J
J Infect; 2007 Feb; 54(2):159-66. PubMed ID: 16690132
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system.
Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C
AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption.
Nemes E; Lugli E; Bertoncelli L; Nasi M; Pinti M; Manzini S; Prati F; Manzini L; Del Giovane C; D'Amico R; Cossarizza A; Mussini C
AIDS; 2011 Jul; 25(12):1443-53. PubMed ID: 21505295
[TBL] [Abstract][Full Text] [Related]
10. [The current status of structured treatment interruption].
Nakata H; Mitsuya H
Nihon Rinsho; 2002 Apr; 60(4):807-12. PubMed ID: 11968793
[TBL] [Abstract][Full Text] [Related]
11. CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.
Okulicz JF; Grandits GA; Weintrob AC; Landrum ML; Ganesan A; Crum-Cianflone NF; Agan BK; Marconi VC
Clin Infect Dis; 2010 Apr; 50(8):1187-91. PubMed ID: 20218878
[TBL] [Abstract][Full Text] [Related]
12. CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l.
Mussini C; Bedini A; Borghi V; Guaraldi G; Esposito R; Barchi E; Enilia R; Cozzi-Lepri A; Philips AN; Ortolani P; Bratt G; Eriksson LE; Sighinolfi L; Cossarizza A; d'Arminio Monforte A; De Luca A; Di Giambenedetto S; Antinori A;
AIDS; 2005 Feb; 19(3):287-94. PubMed ID: 15718839
[TBL] [Abstract][Full Text] [Related]
13. Structured interruptions of highly active antiretroviral therapy in cycles of 4 weeks off/12 weeks on therapy in children having a chronically undetectable viral load cause progressively smaller viral rebounds.
Palacios GC; Sanchez LM; Briones E; Ramirez TJ; Castillo H; Rivera LG; Vazquez CA; Rodriguez-Padilla C; Holodniy M
Int J Infect Dis; 2010 Jan; 14(1):e34-40. PubMed ID: 19467895
[TBL] [Abstract][Full Text] [Related]
14. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
15. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
16. Stopping antiretroviral therapy in 'prematurely treated' HIV-1-infected children with full viral supression is safe.
Reula ES; León-Leal JA; Leal M; Obando I; Muñoz-Fernández A
AIDS; 2006 Jan; 20(2):307-9. PubMed ID: 16511434
[No Abstract] [Full Text] [Related]
17. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
18. Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170).
McLinden RJ; Paris RM; Polonis VR; Close NC; Su Z; Shikuma CM; Margolis DM; Kim JH
AIDS; 2012 Jan; 26(1):1-9. PubMed ID: 21971356
[TBL] [Abstract][Full Text] [Related]
19. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
Grant PM; Zolopa AR
Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
[TBL] [Abstract][Full Text] [Related]
20. Predictors of sustained response to therapy resumption after treatment interruption in HIV-infected patients failing antiretroviral therapy.
Gianotti N; Soria A; Galli L; Castagna A; Cernuschi M; Hasson H; Lazzarin A
J Med Virol; 2004 Feb; 72(2):181-6. PubMed ID: 14695657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
